Last reviewed: May 2026
Choosing a GLP-1 weight loss program in 2026 is harder than it should be. Dozens of telehealth companies advertise compounded semaglutide and tirzepatide, ranging from $150 medication-only delivery services to $1,000+ concierge clinics. The pricing gap reflects real differences in what’s actually included β and what isn’t.
This guide breaks down what separates a real medical program from a medication-only service, what questions to ask before signing up, and the red flags worth watching for.
The Five Things That Separate a Real Medical Program From Medication-Only Telehealth
The cheapest GLP-1 telehealth services have one thing in common: they sell medication. Everything else β physician follow-up, lab monitoring, side effect support, coaching β is either absent or sold separately. A real medical program includes all of these in a single price.
1. Ongoing physician relationship
A real program connects you with a board-certified physician who reviews your intake, prescribes when clinically appropriate, and remains available throughout your program for dose adjustments and clinical questions. Some services advertise “physician oversight” but only provide a single asynchronous review at intake β no ongoing relationship, no follow-up visits, no protocol changes based on how you respond.
Ask any program you’re considering: After my first prescription, how do I reach my prescribing physician? If the answer is a generic support email or a chatbot, the medical relationship is thin.
2. Lab monitoring
GLP-1 medications affect metabolic markers including blood glucose, lipid panel, kidney function, and liver enzymes. Programs that include quarterly metabolic labs let your physician track how your body is actually responding β not just what the scale shows. The cheapest programs skip labs entirely. Some allow you to order labs at additional cost, which means most patients never do.
Ask: Are labs included in the monthly price? If not, what do they cost?
3. Health coaching
GLP-1 medications reduce appetite. They don’t teach you how to eat enough protein, how to maintain muscle mass during weight loss, or how to sustain results after you stop the medication. Coaching is the behavior-change component that determines whether weight stays off long-term. Programs without coaching are betting that the medication alone is sufficient β which the long-term outcome data does not support.
Ask: Is coaching included? How often do I meet with my coach?
4. Side effect management
The most common GLP-1 side effects β nausea, constipation, fatigue, occasional reflux β are usually manageable, but only if someone is actually managing them. Programs with a real care team can adjust your titration schedule, suggest GI support, or pause a dose escalation if you’re struggling. Medication-only services typically have a help desk that escalates to “talk to your doctor” β which is hard when you don’t have a real one.
Ask: If I have side effects, who do I message and how fast do they respond?
5. Transparency about compounded medications
If your program is dispensing compounded semaglutide or tirzepatide, you have a right to know which 503A compounding pharmacy is preparing it. State-licensed 503A pharmacies are subject to state pharmacy board oversight and are the only legal source of compounded GLP-1 preparations under a patient-specific prescription. Some programs decline to name their pharmacy partners; others rotate between multiple. Both are valid, but transparency about the supply chain is a quality signal.
Ask: Which 503A pharmacy is dispensing my medication?
Compounded vs. Brand-Name: Understanding Your Options
The decision between compounded and brand-name GLP-1 medications is more nuanced than “compounded is just cheaper.”
Brand-name GLP-1 medications
Wegovy, Ozempic, Rybelsus, Mounjaro, and Zepbound are FDA-approved finished drug products manufactured by Novo Nordisk or Eli Lilly. They go through the FDA approval process, follow standardized manufacturing protocols, and have been studied in large clinical trials.
The trade-off is access and cost. Without insurance coverage, brand-name GLP-1 medications typically cost $1,000β$1,500 per month at retail. With insurance coverage for weight loss, out-of-pocket costs can be much lower β but prior authorization, formulary restrictions, and in-network prescriber requirements often make the path complicated.
Compounded GLP-1 medications
503A compounding pharmacies prepare semaglutide and tirzepatide under state pharmacy board oversight, pursuant to a patient-specific prescription. These preparations are not FDA-approved as finished drug products. They are dispensed only when a licensed physician determines compounding is clinically appropriate for the individual patient.
The trade-off is cost vs. regulatory framework. Compounded preparations typically cost less per month than brand-name medications and are dispensed without prior authorization, but they operate outside the FDA finished-drug-product approval pathway. Patients should ask their physician about the differences and make an informed choice.
Questions to Ask Before You Sign Up
Before committing to any GLP-1 program, get clear answers to these:
- What’s the total monthly cost? Some programs advertise a low base price and add medication, labs, or coaching as upgrades. Ask for the all-in number.
- Are physician visits included? If yes, how many per year, and how do I schedule them?
- Are labs included? If yes, what panel and how often? If no, what do they cost separately?
- Who is my prescribing physician? Is it the same physician for follow-up, or am I rotating through whoever is available?
- What 503A pharmacy is dispensing my medication? Reputable programs will name their partners.
- What’s the cancellation policy? Can I cancel anytime, or am I locked into a multi-month contract?
- What happens if I have side effects? Who do I reach, and how quickly?
- Is health coaching included? If yes, what does that look like?
Red Flags Worth Watching For
- Medication-only services with no real care team. A subscription that includes only the medication and a help desk isn’t a medical program β it’s a delivery service.
- Programs that don’t disclose their compounding pharmacy partners. Transparency about the supply chain is a basic quality signal.
- Unrealistic outcome claims. Any program promising specific weight loss numbers, before-and-after results, or “guaranteed” success is making claims they can’t substantiate. GLP-1 outcomes vary widely by individual.
- Trademark blurring. Some marketing materials suggest compounded semaglutide is “the same as Wegovy” or “the same as Ozempic.” Compounded preparations are not FDA-approved finished drug products and should not be marketed as equivalent to brand-name medications. The active pharmaceutical ingredient may be the same; the regulatory framework, manufacturing process, and clinical trial data are not.
- Steeply discounted introductory pricing that reverts later. Some programs offer a heavily discounted first month, then jump to a higher steady-state price. Ask what you’ll pay in month two, three, and beyond.
How Elara Approaches This
Elara’s program is structured around the framework above. Every monthly subscription includes compounded semaglutide or tirzepatide prepared by one of our state-licensed 503A compounding pharmacy partners β RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, or Triad Rx β quarterly metabolic labs to track your clinical progress, ongoing access to a board-certified physician for dose adjustments and questions, and dedicated certified health coaches for nutrition and behavior change support. And if you have surgery or another procedure scheduled while on therapy, your program should be able to coordinate disclosure with your surgical team — we cover the protocol in our guide to GLP-1 use before surgery. Single monthly price, no upsells, cancel anytime.
Learn more about Elara’s GLP-1 program or take our 5-minute assessment to see if compounded therapy might be appropriate for you.
Related reading: The 2026 Guide to Physician-Guided GLP-1 Care: Choose a Program That Fits Real Life Β· GLP-1 Therapy in 2026: What to Know Before Starting a Physician-Guided Weight Loss Program
Medical review: This article has been reviewed by board-certified physicians within Elara’s telehealth provider network. Last reviewed: May 2026.
Compounded semaglutide and tirzepatide are prepared by state-licensed 503A compounding pharmacies under state pharmacy board oversight, pursuant to patient-specific prescriptions issued by board-certified physicians. These medications are not FDA-approved as finished drug products. GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Wegovy®, Ozempic®, Rybelsus®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers and are not affiliated with Elara Health and Wellness. Results vary and are not guaranteed. This content is for informational purposes only and is not a substitute for professional medical advice. Consult your physician before starting any treatment.